Authors:
Kurt, MA
Davies, DC
Kidd, M
Duff, K
Rolph, SC
Jennings, KH
Howlett, DR
Citation: Ma. Kurt et al., Neurodegenerative changes associated with beta-amyloid deposition in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes, EXP NEUROL, 171(1), 2001, pp. 59-71
Authors:
Hussain, I
Powell, DJ
Howlett, DR
Chapman, GA
Gilmour, L
Murdock, PR
Tew, DG
Meek, TD
Chapman, C
Schneider, K
Ratcliffe, SJ
Tattersall, D
Testa, TT
Southan, C
Ryan, DM
Simmons, DL
Walsh, FS
Dingwall, C
Christie, G
Citation: I. Hussain et al., ASP1 (BACE2) cleaves the amyloid precursor protein at the beta-secretase site, MOL CELL NE, 16(5), 2000, pp. 609-619
Authors:
Ward, RV
Jennings, KH
Jepras, R
Neville, W
Owen, DE
Hawkins, J
Christie, G
Davis, JB
George, A
Karran, EH
Howlett, DR
Citation: Rv. Ward et al., Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of beta-amyloid peptide, BIOCHEM J, 348, 2000, pp. 137-144
Authors:
Howlett, DR
Simmons, DL
Dingwall, C
Christie, G
Citation: Dr. Howlett et al., In search of an enzyme: the beta-secretase of Alzheimer's disease is an aspartic proteinase, TRENDS NEUR, 23(11), 2000, pp. 565-570
Authors:
Hussain, I
Powell, D
Howlett, DR
Tew, DG
Week, TD
Chapman, C
Gloger, IS
Murphy, KE
Southan, CD
Ryan, DM
Smith, TS
Simmons, DL
Walsh, FS
Dingwall, C
Christie, G
Citation: I. Hussain et al., Identification of a novel aspartic protease (Asp 2) as beta-secretase, MOL CELL NE, 14(6), 1999, pp. 419-427
Authors:
Howlett, DR
George, AR
Owen, DE
Ward, RV
Markwell, RE
Citation: Dr. Howlett et al., Common structural features determine the effectiveness of carvedilol, daunomycin and rolitetracycline as inhibitors of Alzheimer beta-amyloid fibril formation, BIOCHEM J, 343, 1999, pp. 419-423
Authors:
Howlett, DR
Perry, AE
Godfrey, F
Swatton, JE
Jennings, KH
Spitzfaden, C
Wadsworth, H
Wood, SJ
Markwell, RE
Citation: Dr. Howlett et al., Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans, BIOCHEM J, 340, 1999, pp. 283-289
Authors:
Christie, G
Markwell, RE
Gray, CW
Smith, L
Godfrey, F
Mansfield, F
Wadsworth, H
King, R
McLaughlin, M
Cooper, DG
Ward, RV
Howlett, DR
Hartmann, T
Lichtenthaler, SF
Beyreuther, K
Underwood, J
Gribble, SK
Cappai, R
Masters, CL
Tamaoka, A
Gardner, RL
Rivett, AJ
Karran, EH
Allsop, D
Citation: G. Christie et al., Alzheimer's disease: Correlation of the suppression of beta-amyloid peptide secretion from cultured cells with inhibition of the chymotrypsin-like activity of the proteasome, J NEUROCHEM, 73(1), 1999, pp. 195-204
Citation: Ar. George et Dr. Howlett, Computationally derived structural models of the beta-amyloid found in Alzheimer's disease plaques and the interaction with possible aggregation inhibitors, BIOPOLYMERS, 50(7), 1999, pp. 733-741